1. Home
  2. SYBX vs CPOP Comparison

SYBX vs CPOP Comparison

Compare SYBX & CPOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • CPOP
  • Stock Information
  • Founded
  • SYBX N/A
  • CPOP 2007
  • Country
  • SYBX United States
  • CPOP China
  • Employees
  • SYBX N/A
  • CPOP N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • CPOP Services-Misc. Amusement & Recreation
  • Sector
  • SYBX Health Care
  • CPOP Consumer Discretionary
  • Exchange
  • SYBX Nasdaq
  • CPOP Nasdaq
  • Market Cap
  • SYBX 15.9M
  • CPOP 17.9M
  • IPO Year
  • SYBX N/A
  • CPOP 2021
  • Fundamental
  • Price
  • SYBX $1.43
  • CPOP $1.14
  • Analyst Decision
  • SYBX Buy
  • CPOP
  • Analyst Count
  • SYBX 4
  • CPOP 0
  • Target Price
  • SYBX $15.50
  • CPOP N/A
  • AVG Volume (30 Days)
  • SYBX 11.4K
  • CPOP 99.3K
  • Earning Date
  • SYBX 11-12-2024
  • CPOP 11-29-2024
  • Dividend Yield
  • SYBX N/A
  • CPOP N/A
  • EPS Growth
  • SYBX N/A
  • CPOP N/A
  • EPS
  • SYBX N/A
  • CPOP N/A
  • Revenue
  • SYBX $2,777,000.00
  • CPOP $47,381,918.00
  • Revenue This Year
  • SYBX N/A
  • CPOP N/A
  • Revenue Next Year
  • SYBX N/A
  • CPOP N/A
  • P/E Ratio
  • SYBX N/A
  • CPOP N/A
  • Revenue Growth
  • SYBX 292.23
  • CPOP 155.52
  • 52 Week Low
  • SYBX $1.22
  • CPOP $0.91
  • 52 Week High
  • SYBX $5.12
  • CPOP $9.67
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 50.79
  • CPOP 42.01
  • Support Level
  • SYBX $1.37
  • CPOP $1.18
  • Resistance Level
  • SYBX $1.45
  • CPOP $1.45
  • Average True Range (ATR)
  • SYBX 0.07
  • CPOP 0.08
  • MACD
  • SYBX 0.00
  • CPOP -0.01
  • Stochastic Oscillator
  • SYBX 31.82
  • CPOP 3.17

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About CPOP Pop Culture Group Co. Ltd

Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from our Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts.

Share on Social Networks: